Solventum (SOLV)

The company’s largest segment is MedSurg, which supplies products used across patient care and clinical settings. This includes wound care and negative pressure wound therapy, surgical supplies, I.V. site management products, medical tapes and wraps, stethoscopes, electrodes, and original equipment manufacturer technologies for medical device makers. These products are often embedded in everyday hospital and outpatient procedures, making reliability, regulatory compliance, and clinician trust important parts of the business.

Solventum also operates Dental Solutions, which provides restorative, preventive, and orthodontic products such as bonding agents, cements, brackets, and related dental materials. Its Health Information Systems business offers software and data tools that support physician documentation, medical coding, speech recognition, revenue cycle workflows, and healthcare analytics. Through its Purification and Filtration activities, the company also serves biopharma, medical, and industrial customers that require high-performance filtration and separation technologies.

The United States is Solventum’s largest market, but the company sells internationally and serves customers across a broad healthcare ecosystem. As a stock, Solventum is linked to demand for medical procedures, hospital spending, dental care, healthcare digitisation, and the company’s ability to innovate while managing regulation, supply chains, and post-spin operational independence.